Catalio Capital Management, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001958125

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q4 2024 · 33 positions · Total reported value $457.14M · Top-10 concentration 57.3% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 63.5% · 13 new · 14 cut · 6 exited

Active Share (vs S&P 500): 98.9% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

In its Q4 2024 13F filing, Catalio Capital Management, LP disclosed 33 equity positions with a combined reported value of $457.14M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 57.3% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2024 were BDX ($33.72M), ASND ($29.68M), BMY ($28.23M). By sector, the heaviest allocations are Health Care 79.5%, Other 20.5%.

Versus the prior quarter, Catalio Capital Management, LP opened 13 new positions, trimmed 14 and fully exited 6, a turnover rate of 63.5% of positions.

The largest new positions opened in Q4 2024 were BDX ($33.72M), ASND ($29.68M), BMY ($28.23M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2024)

  • BDX BECTON DICKINSON & CO · $33.72M
  • ASND ASCENDIS PHARMA A/S · $29.68M
  • BMY BRISTOL-MYERS SQUIBB CO · $28.23M
  • SWTX SPRINGWORKS THERAPEUTICS INC · $27.63M
  • BPMC BLUEPRINT MEDICINES CORP · $24.83M
  • EW EDWARDS LIFESCIENCES CORP · $24.66M
  • BBIO BRIDGEBIO PHARMA INC · $24.65M
  • LIVN LIVANOVA PLC · $23.73M

Fully Exited (vs previous quarter)

No tracked position was fully exited this quarter.

Insider Transactions (Form 4)

Latest Catalio Capital Management, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-10-16 Conversion Iambic Therapeutics, Inc. 742,546 — SEC filing
2026-10-16 Conversion Iambic Therapeutics, Inc. 1,458,290 — SEC filing
2026-10-16 Conversion Iambic Therapeutics, Inc. 1,995,749 — SEC filing

All insider transactions →

Fund Profile

Catalio Capital Management, LP is an SEC-registered 13F filer based in New York, NY, United States. As of Q3 2026 it reported 46 US equity positions with a combined value of $535.82M. HoldingsHub carries 8 quarters of its filings (Q4 2024–Q3 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-121976 (status: Approved), registered 2021-07-30
  • Regulatory AUM (Form ADV): $1.93B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 78%, pooled investment vehicles 13%
  • Manages 23 private funds, of which 1 hedge funds

Portfolio Structure

  • 46 positions · $535.82M reported value (Q3 2026)
  • Top 10 holdings = 48.7% of reported value
  • Largest position: AVLN (AVALYN PHARMACEUTICALS INC) at 9.0%
  • Average position size: $11.65M

Sector Tilt

  • Health Care 96.3%
  • Industrials 2.8%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q3 2026: 13 new, 13 added, 14 reduced, 6 exited
  • 6 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 79.5%
Other 20.5%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 148.62K $33.72M 7.38%
7.38%
New
2 215.59K $29.68M 6.49%
6.49%
New
3 499.15K $28.23M 6.18%
6.18%
New
4 764.67K $27.63M 6.04%
6.04%
New
5 284.65K $24.83M 5.43%
5.43%
New
6 333.14K $24.66M 5.39%
5.39%
New
7 898.46K $24.65M 5.39%
5.39%
New
8 512.45K $23.73M 5.19%
5.19%
New
9 1.02M $23.46M 5.13%
5.13%
New
10 457.59K $21.52M 4.71%
4.71%
New
11 1.02M $19.67M 4.30%
4.30%
New
12 490.55K $19.43M 4.25%
4.25%
New
13 36.91K $19.27M 4.21%
4.21%
New
14 309.10K $17.37M 3.80%
3.80%
New
15 763.47K $16.64M 3.64%
3.64%
New
16 901.97K $15.93M 3.48%
3.48%
New
17 569.39K $15.44M 3.38%
3.38%
New
18 87.38K $14.44M 3.16%
3.16%
New
19 179.81K $11.40M 2.49%
2.49%
New
20 512.72K $8.79M 1.92%
1.92%
New
21 132.54K $6.77M 1.48%
1.48%
New
22 72.92K $6.51M 1.43%
1.43%
New
23 407.29K $6.45M 1.41%
1.41%
New
24 1.09M $5.75M 1.26%
1.26%
New
25 1.71M $2.44M 0.53%
0.53%
New
26 586.91K $2.20M 0.48%
0.48%
New
27 528.99K $1.91M 0.42%
0.42%
New
28 2.33M $1.58M 0.34%
0.34%
New
29 187.18K $1.53M 0.34%
0.34%
New
30 760.03K $668.83K 0.15%
0.15%
New
31 214.24K $441.33K 0.10%
0.10%
New
32 196.86K $261.82K 0.06%
0.06%
New
33 294.37K $144.27K 0.03%
0.03%
New

FAQ

What did Catalio Capital Management, LP buy in 2024-Q4?

In its 2024-Q4 13F filing, Catalio Capital Management, LP reported 33 equity positions worth $457.14M in aggregate; its largest disclosed positions were BDX ($33.72M), ASND ($29.68M), BMY ($28.23M).

How large is Catalio Capital Management, LP's portfolio?

Catalio Capital Management, LP reported $457.14M of long equity holdings across 33 positions as of 2024-Q4. Top-10 holdings account for 57.3% of reported value.

What is Catalio Capital Management, LP's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/catalio-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →